464 related articles for article (PubMed ID: 28879545)
1. Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data.
Davies B; Gaul C; Martelletti P; García-Moncó JC; Brown S
J Headache Pain; 2017 Sep; 18(1):93. PubMed ID: 28879545
[TBL] [Abstract][Full Text] [Related]
2. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.
Ahmed F; Gaul C; García-Moncó JC; Sommer K; Martelletti P;
J Headache Pain; 2019 Mar; 20(1):26. PubMed ID: 30845917
[TBL] [Abstract][Full Text] [Related]
3. Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study.
Kollewe K; Gaul C; Gendolla A; Sommer K
J Headache Pain; 2021 Jun; 22(1):50. PubMed ID: 34078259
[TBL] [Abstract][Full Text] [Related]
4. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
Negro A; Curto M; Lionetto L; Martelletti P
J Headache Pain; 2015; 17():1. PubMed ID: 26792662
[TBL] [Abstract][Full Text] [Related]
5. Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
Blumenfeld AM; Stark RJ; Freeman MC; Orejudos A; Manack Adams A
J Headache Pain; 2018 Feb; 19(1):13. PubMed ID: 29404713
[TBL] [Abstract][Full Text] [Related]
6. Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe.
Matharu M; Pascual J; Nilsson Remahl I; Straube A; Lum A; Davar G; Odom D; Bennett L; Proctor C; Gutierrez L; Andrews E; Johannes C
Cephalalgia; 2017 Dec; 37(14):1384-1397. PubMed ID: 28758415
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.
Kollewe K; Escher CM; Wulff DU; Fathi D; Paracka L; Mohammadi B; Karst M; Dressler D
J Neural Transm (Vienna); 2016 May; 123(5):533-40. PubMed ID: 27032774
[TBL] [Abstract][Full Text] [Related]
8. Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
Santoro A; Fontana A; Miscio AM; Zarrelli MM; Copetti M; Leone MA
Neurol Sci; 2017 Oct; 38(10):1779-1789. PubMed ID: 28726049
[TBL] [Abstract][Full Text] [Related]
9. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
10. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
[TBL] [Abstract][Full Text] [Related]
11. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
12. Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.
Blumenfeld AM; Aurora SK; Laranjo K; Papapetropoulos S
BMC Neurol; 2015 Jul; 15():100. PubMed ID: 26133547
[TBL] [Abstract][Full Text] [Related]
13. Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.
Young WB; Ivan Lopez J; Rothrock JF; Orejudos A; Manack Adams A; Lipton RB; Blumenfeld AM
J Headache Pain; 2019 Feb; 20(1):12. PubMed ID: 30709333
[TBL] [Abstract][Full Text] [Related]
14. Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.
Rothrock JF; Bloudek LM; Houle TT; Andress-Rothrock D; Varon SF
Headache; 2014; 54(10):1565-73. PubMed ID: 25298117
[TBL] [Abstract][Full Text] [Related]
15. Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation.
Bendtsen L; Sacco S; Ashina M; Mitsikostas D; Ahmed F; Pozo-Rosich P; Martelletti P
J Headache Pain; 2018 Sep; 19(1):91. PubMed ID: 30259200
[TBL] [Abstract][Full Text] [Related]
16. Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.
Guerzoni S; Pellesi L; Baraldi C; Pini LA
J Headache Pain; 2015; 17():48. PubMed ID: 27146068
[TBL] [Abstract][Full Text] [Related]
17. Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK.
Hollier-Hann G; Curry A; Onishchenko K; Akehurst R; Ahmed F; Davies B; Keyzor I
J Med Econ; 2020 Jan; 23(1):113-123. PubMed ID: 31578100
[No Abstract] [Full Text] [Related]
18. OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.
Boudreau G; Finkelstein I; Graboski C; Ong M; Christie S; Sommer K; Bhogal M; Davidovic G; Becker WJ
Can J Neurol Sci; 2022 Jul; 49(4):540-552. PubMed ID: 34218836
[TBL] [Abstract][Full Text] [Related]
19. Development of onabotulinumtoxinA for chronic migraine.
Whitcup SM; Turkel CC; DeGryse RE; Brin MF
Ann N Y Acad Sci; 2014 Nov; 1329():67-80. PubMed ID: 25399521
[TBL] [Abstract][Full Text] [Related]
20. OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study.
Becker WJ; Boudreau G; Finkelstein I; Graboski C; Ong M; Christie S; Sommer K; Bhogal M; Davidovic G
Can J Neurol Sci; 2023 May; 50(3):418-427. PubMed ID: 35466897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
